Amanta Healthcare share price hits 5% upper circuit after decent listing. Should you buy, hold or sell?

Amanta Healthcare IPO listing was in line with muted Street expectations, as indicated by the grey market premium (GMP). Amanta Healthcare IPO GMP today ahead of the listing was 9 per share.

Ankit Gohel
Published9 Sep 2025, 02:31 PM IST
Amanta Healthcare shares were listed at  <span class='webrupee'>₹</span>135 apiece on NSE, a premium of 7.14% over its issue price.
Amanta Healthcare shares were listed at ₹135 apiece on NSE, a premium of 7.14% over its issue price.(Photo: Company Website)

Amanta Healthcare share price was locked-in at 5% upper circuit after making a decent debut in the Indian stock market today. Amanta Healthcare IPO listing date was today, September 9, and the equity shares of the company are listed on BSE and NSE.

Amanta Healthcare shares were listed at 135 apiece on NSE, a premium of 7.14% over its issue price of 126 per share. On BSE, the stock was listed with a 6.35% premium at 134 apiece.

The stock rallied after listing and hit a high of 140.65 apiece on the BSE, up 5% from listing price, and up 11.63% from issue price.

Also Read | Amanta Healthcare lists at ₹135 on NSE, a premium of 7% over IPO price

Amanta Healthcare IPO listing was in line with muted Street expectations, as indicated by the grey market premium (GMP). Amanta Healthcare IPO GMP today ahead of the listing was 9 per share.

Here’s what investors should do with Amanta Healthcare shares after listing:

Should you buy, sell or hold Amanta Healthcare shares after listing?

Amanta Healthcare IPO listing on the stock exchanges has been well-received, reflecting strong market confidence in its specialty healthcare offerings.

Amanta Healthcare is poised to benefit from expansion into high-demand therapeutic categories, deeper penetration into hospital and retail chains, and ongoing product innovation. While short-term volatility may occur due to market rotations, the company’s strong fundamentals and disciplined execution make it well-positioned for sustainable earnings growth and long-term value creation in India’s healthcare sector,” said Kalp Jain Research Analyst, INVasset PMS.

Also Read | Urban Company IPO opens tomorrow. GMP, date, review, other details in 10 points

In FY25, Amanta delivered revenue growth of ~18–20%, supported by healthy margins and scale benefits across its product portfolio. The IPO proceeds, primarily intended for capacity expansion and debt reduction, provide a clear pathway for margin improvement and enhanced operational efficiency, he added.

“Early post-listing trading suggests that the market is recognizing the company’s structural growth trajectory and ability to capitalize on sectoral demand trends,” Jain said.

Amanta Healthcare IPO was open from September 1 to 3 and was subscribed 82.61 times in total. The company raised 126 crore from the book-building issue which was entirely a fresh issue of 1 crore equity shares, sold at an IPO price band of 120 to 126 per share.

At 2:30 PM, Amanta Healthcare shares were at 140.65 apiece on the BSE, up 5% from listing price, and up 11.63% from its IPO price.

Read Amanta Healthcare Share Price Live Updates here

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Amanta HealthcareIPO Listing
Get Latest real-time updates

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Business NewsMarketsStock MarketsAmanta Healthcare share price hits 5% upper circuit after decent listing. Should you buy, hold or sell?
More